Indian Pharmaceutical Research Laboratories Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 08-12-2024
- Paid Up Capital ₹ 0.10 M
as on 08-12-2024
- Company Age 28 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 8.50 M
as on 08-12-2024
About Indian Pharmaceutical Research Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹8.50 M.
Sujata Parmaj and Ronak Parmaj serve as directors at the Company.
- CIN/LLPIN
U52310MH1996PTC097811
- Company No.
097811
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Mar 1996
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Indian Pharmaceutical Research Laboratories?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sujata Parmaj  | Additional Director | 17-Aug-2024 | Current |
| Ronak Parmaj | Additional Director | 17-Aug-2024 | Current |
Financial Performance of Indian Pharmaceutical Research Laboratories.
Enhance accessibility to Indian Pharmaceutical Research Laboratories's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Indian Pharmaceutical Research Laboratories?
Unlock access to Indian Pharmaceutical Research Laboratories's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Parmaj Agrotech Private LimitedActive 3 years 7 monthsSujata Parmaj and Ronak Parmaj are mutual person
- Parmaj Industries Private LimitedActive 2 years 2 months
Sujata Parmaj and Ronak Parmaj are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 15 Mar 2024 | ₹4.00 M | Open |
Others Creation Date: 14 Feb 2024 | ₹4.50 M | Open |
How Many Employees Work at Indian Pharmaceutical Research Laboratories?
Unlock and access historical data on people associated with Indian Pharmaceutical Research Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Indian Pharmaceutical Research Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Indian Pharmaceutical Research Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
